0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover1112.87%IV-139.62%PremiumDec 20, 2024Expiry Date4.37Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8531Delta0.1151Gamma0.70Leverage Ratio-0.1166Theta-0.0002Rho-0.60Eff Leverage0.0004Vega
Kazia Therapeutics Stock Discussion
Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
Wednesday, 11th December at 8:00 am
SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast Cancer Symposium ...
📊⚡️📊
Larger Image: tradingview.com...
$Kazia Therapeutics (KZIA.US)$
📊⚡️📊
📊⚡️📊
No comment yet